(Q63579014)
Statements
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Dupilumab in Chinese Adult Patients With Moderate to Severe Atopic Dermatitis (English)
0 references
17 December 2018
0 references
April 2020
0 references
160
0 references
18 year
0 references